IP Library Granted Patent US 10,383,748
Granted Patent B2
US 10,383,748 · App. 15/611,154 · Granted Aug 20, 2019

Procedures for vascular occlusion

Inventors: Aaron Lee Berez (Portola Valley, CA); Quang Quoc Tran (Atherton, CA)
Assignee: Covidien LP
A61F2/82A61B17/12036A61B17/12109A61B17/12118A61B17/12172A61B17/320758A61F2/01A61F2/06A61F2/852A61F2/90A61F2/95A61M5/007A61M25/00A61M29/00A61B17/12177A61B2017/00336A61B2017/1205A61B2017/12054A61B2017/22079A61B2017/320716A61B2017/320766A61B2017/320791A61B2090/3966A61F2/013A61F2/966A61F2002/011A61F2002/823A61F2002/826A61F2002/9528A61F2230/0078A61F2230/0091A61F2230/0095A61F2250/0018A61F2250/0026A61F2250/0065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,383,748
App. No.
15/611,154
Granted
Aug 20, 2019
Kind
B2
Abstract

A method of reducing blood flow within an aneurysm includes: injecting a contrast agent into a blood vessel including an aneurysm; expanding a stent, from a delivery device, across the aneurysm; and confirming that a stagnated area forms in the aneurysm. The stagnated area can form a crescent shape, a mushroom shape, a hemispherical shape, and/or a flat side. Upon confirming that the stagnated area forms in the aneurysm, the delivery device can be withdrawn from the blood vessel. The stagnated area can include the contrast agent. If the stagnated area does not form in the aneurysm, a second occluding device may be deployed. After withdrawing the delivery device, substantially all of the aneurysm progressively thromboses.

Claims (31)

1. A method of reducing blood flow within an aneurysm of a blood vessel, the method comprising:

expanding a stent, from a delivery device, across the aneurysm, such that a stagnated area forms in the aneurysm;

injecting a contrast agent into the blood vessel;

confirming that the stagnated area forms one or more predetermined shapes indicating the stagnated area occupies less than 70% of a body of the aneurysm; and

while the stagnated area has formed the one or more predetermined shapes, withdrawing the delivery device from the blood vessel.

2. The method of claim 1 , wherein the stagnated area comprises the contrast agent.

3. The method of claim 1 , wherein the delivery device comprises a catheter.

4. The method of claim 1 , wherein, after withdrawing the delivery device, substantially all of the aneurysm progressively thromboses.

5. The method of claim 1 , wherein the confirming is sufficient to determine that the expanding the stent is sufficient to lead to thrombosis of the aneurysm.

6. The method of claim 1 , wherein the one or more predetermined shape(s) include a crescent shape, a mushroom shape, a hemispherical shape, and/or a flat side.

7. The method of claim 1 , wherein the confirming comprises confirming that the stagnated area fills between about 20% and about 70% of a volume of the aneurysm.

8. The method of claim 1 , wherein the confirming comprises confirming that the stagnated area fills between about 50% and about 70% of a volume of the aneurysm.

9. The method of claim 1 , wherein the confirming comprises comparing a first image of the aneurysm before expanding the stent to a second image of the aneurysm after expanding the stent.

10. A method of reducing blood flow within an aneurysm of a blood vessel, the method comprising:

expanding a stent, from a delivery device, across the aneurysm, whereby a stagnated area forms one or more predetermined shapes indicating the stagnated area occupies less than 70% of the volume of the aneurysm;

injecting a contrast agent into the blood vessel, at least a portion of the contrast agent flowing into the aneurysm; and

withdrawing the delivery device from the blood vessel upon confirming that the stagnated area forms the one or more predetermined shapes.

11. The method of claim 10 , wherein the stagnated area comprises the contrast agent.

12. The method of claim 10 , wherein the delivery device comprises a catheter.

13. The method of claim 10 , wherein the confirming is sufficient to determine that the expanding the stent is sufficient to lead to thrombosis of the aneurysm.

14. The method of claim 10 , wherein the one or more predetermined shape(s) include a crescent shape, a mushroom shape, a hemispherical shape, and/or a flat side.

15. The method of claim 10 , wherein the stagnated area fills between about 20% and about 70% of a volume of the aneurysm when the delivery device is withdrawn from the blood vessel.

16. The method of claim 10 , wherein the stagnated area fills about 50% and about 70% of a volume of the aneurysm when the delivery device is withdrawn from the blood vessel.

17. A method of reducing blood flow within an aneurysm of a blood vessel, the method comprising:

expanding a stent, from a delivery device, across the aneurysm;

injecting a contrast agent into the blood vessel; and

withdrawing the delivery device from the blood vessel upon confirming that the aneurysm has formed a stagnated area comprising one or more predetermined shapes indicating the stagnated area fills less than 70% of the volume of the aneurysm;

wherein, after withdrawing the delivery device, substantially all of the aneurysm progressively thromboses.

18. The method of claim 17 , wherein the stagnated area comprises the contrast agent.

19. The method of claim 17 , wherein the delivery device comprises a catheter.

20. The method of claim 17 , wherein withdrawing the delivery device from the blood vessel comprises releasing the stent from the delivery device.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2019
From: BEREZ, AARON LEE; TRAN, QUANG QUOC
To: CHESTNUT MEDICAL TECHNOLOGIES, INC.
Reel/Frame 049566/0525 →
MERGER Recorded Jun 24, 2019
From: CHESTNUT MEDICAL TECHNOLOGIES, INC.
To: EV3 INC.
Reel/Frame 049568/0566 →
CHANGE OF NAME Recorded Jun 24, 2019
From: EV3 INC.
To: EV3 LLC
Reel/Frame 049568/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2019
From: EV3 LLC
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 049568/0737 →
CHANGE OF NAME Recorded Jun 24, 2019
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 049568/0756 →
Continuity (6)
Continuation 15204850 · Jul 7, 2016
Continuation 14791617 · Jul 6, 2015
Continuation 13652591 · Oct 16, 2012
Continuation 12751997 · Mar 31, 2010
Provisional Application 61288525 · Dec 21, 2009
Related Publication 20170304087A1 · Oct 26, 2017